Bone growth factors and inhibitors of bone resorption for promoting bone formation
Patent 5118667 Issued on June 2, 1992. Estimated Expiration Date: 
May 3, 2011. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
May 3, 2011. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesBone morphogenetic protein process Partially purified osteogenic factor and process for preparing same from demineralized bone Bone morphogenetic protein Bone protein purification process Patent #: 4608199 InventorsAssigneeApplicationNo. 695310 filed on 05/03/1991US Classes:514/12, 25 or more peptide repeating units in known peptide chain structure514/8, Glycoprotein (carbohydrate containing)514/21Produced by or extracted from animal tissueExaminersPrimary: Schain, Howard E.Assistant: Koh, Choon P. Attorney, Agent or FirmForeign Patent References
International ClassesA61K 037/36A61K 037/43 AbstractBone growth factors are used to stimulate new bone formation when administered with agents that inhibit bone resorption. These therapeutic combinations result in an enhanced rate of bone formation with an increase in bone mass.Other References
| |
